Clinical imaging
Neurovascular disease, neuro-oncology and diagnostic performance.
MICROSCOPIA RESEARCH GROUP
A sustained scientific agenda, expert supervision and shared execution capacity.
Physician and radiologist trained at Universidad Industrial de Santander (Bucaramanga, Colombia) and Universidad de Cartagena (Cartagena, Colombia). He teaches radiology at Universidad Industrial de Santander and leads neuroradiology at Hospital Internacional de Colombia (Piedecuesta, Colombia). His academic work brings together neuroradiology, clinical research and responsible evaluation of imaging artificial intelligence.
Neurovascular disease, neuro-oncology and diagnostic performance.
Systematic reviews, meta-analysis and clinical epidemiology.
External validation, transportability and clinical utility.
Active microscopIA members may apply. Students, early-career professionals, clinicians, engineers and experienced investigators contribute in roles matched to their preparation. Admission depends on scientific fit, supervision and available capacity.
Submit your CV, interests, membership email and weekly availability.
The scientific lead reviews your application and proposed role.
Confirm supervision, training, milestones and applicable permissions before research starts.
Bring scientific leadership and a sustained research program. We review the proposal, required resources and recruitment plan before agreeing the group’s scope.
Proposed group name, purpose and scientific priorities.
Proposed leader’s CV, relevant expertise and supervision capacity.
At least three distinct projects: question, design, data sources, permissions, timeline and expected outputs.
Member recruitment: roles, places, qualifications, languages, weekly commitment and selection criteria.
Resources requested, existing support, conflicts of interest and proposed data and intellectual-property arrangements.
Applications to join established groups are open throughout the year to active members, subject to fit and capacity. Group approval does not automatically approve its projects.